Press release – Sus Clinicals

Press release

MED Institute and Sus Clinicals Announce Strategic Collaboration to Advance Preclinical Testing for Medical Product Innovation

WEST LAFAYETTE, Ind.–(BUSINESS WIRE)–MED Institute, a leader in pre-clinical and clinical medical product development services, is proud to announce a strategic collaboration with Sus Clinicals, a pioneering provider of genetic-modified…

Sus Clinicals Announces New Chief Executive Officer

Experienced Pharmaceuticals and Oncology Executive to Assume Leadership Role Cincinnati, OH and Boston, MA, July 29, 2024 — Sus Clinicals, Inc.® announced today that Jessicca M. Rege, Ph.D. has been…

Sus Clinicals Appoints Dr. Lawrence Schook to Board of Directors

Sus Clinicals, Inc. announced today that Dr. Lawrence Schook has been elected to the Company’s Board of Directors

Sus Clinicals, Inc. Announces $2 Million Research Grant from the National Institutes of Health

Funding will support breakthrough work against an aggressive form of liver cancer

Sus Clinicals, Inc. Announces Former Jackson Labs Executive Joins the Company as Advisor

Dr. Auro Nair brings over three decades of experience in life sciences and biomedical research

Sus Clinicals, Inc. Announces Formation of Advisory Council

Top experts to advise Company on scientific priorities and innovation strategies

Sus Clinicals Announces Former McKinsey Executive Joins the Company as Advisor

Jeff Sinclair brings 30+ years of experience in strategy, operations and organization design

Sus Clinicals, Inc. Receives Clearance from the U.S. Food & Drug Administration

Grant of Enforcement Discretion Supports Commercial Launch

Sus Clinicals, Inc. Announces New License Agreement for Advancement in Cancer-Related Research

Patent-Pending Technology from the University of Illinois Leverages Large Animal Model to Accelerate Pre-Clinical Testing for Cancer Therapies